Metabolic differences among newborns born to mothers with a history of leukemia or lymphoma

References

• Barbosa-Cortés L, López-Alarcón M, Mejía-Aranguré JM, et al. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country. BMC Cancer. 2017;17(1):125.
   PubMedGoogle Scholar
• Barnea D, Raghunathan N, Friedman DN, et al. Obesity and metabolic disease after childhood cancer. Oncology. 2015;29(11):849–855.
   PubMed Web of Science ®Google Scholar
• Fournier M, Bonneil E, Garofalo C, et al. Altered proteome of high-density lipoproteins from paediatric acute lymphoblastic leukemia survivors. Sci Rep. 2019;9(1):4268.
   PubMedGoogle Scholar
• Karakaya P, Yılmaz S, Tüfekçi O, et al. Endocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia. Turk J Haematol. 2013;30(3):290–299.
   PubMed Web of Science ®Google Scholar
• Malhotra J, Tonorezos ES, Rozenberg M, et al. Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia. J Lipid Res. 2012;53(12):2747–2754.
   PubMed Web of Science ®Google Scholar
• Morel S, Leahy J, Fournier M, et al. Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors. J Lipid Res. 2017;58(5):982–993.
   PubMed Web of Science ®Google Scholar
• Meacham LR, Sklar CA, Li S, et al. Diabetes mellitus in long-term survivors of childhood cancer. Arch Intern Med. 2009;169(15):1381–1388.
   PubMedGoogle Scholar
• Jung H-S, Myung S-K, Kim B-S, et al. Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract. 2012;95(2):275–282.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Kwak S-Y, Jo G, et al. Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study. Sci Rep. 2018;8(1):8207.
   PubMedGoogle Scholar
• Yun JH, Lee H-S, Yu H-Y, et al. Metabolomics profiles associated with HbA1c levels in patients with type 2 diabetes. PloS One. 2019;14(11):e0224274.
   PubMed Web of Science ®Google Scholar
• Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13(4):227–232.
   PubMed Web of Science ®Google Scholar
• Xiong J. Fatty acid oxidation in cell fate determination. Trends Biochem Sci. 2018;43(11):854–857.
   PubMed Web of Science ®Google Scholar
• Heber D, Byerly LO, Chlebowski RT. Metabolic abnormalities in the cancer patient. Cancer. 1985;55(S1):225–229.
   PubMedGoogle Scholar
• Lai HS, Lee JC, Lee PH, et al. Plasma free amino acid profile in cancer patients. Semin Cancer Biol. 2005;15(4):267–276.
   PubMed Web of Science ®Google Scholar
• Miyagi Y, Higashiyama M, Gochi A, et al. Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PloS One. 2011;6(9):e24143.
   PubMed Web of Science ®Google Scholar
• Proenza AM, Oliver J, Palou A, et al. Breast and lung cancer are associated with a decrease in blood cell amino acid content. J Nutr Biochem. 2003;14(3):133–138.
   PubMed Web of Science ®Google Scholar
• Tiziani S, Lopes V, Gunther UL. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia. 2009;11(3):269–276.
   PubMed Web of Science ®Google Scholar
• Cui M, Wang Q, Chen G. Serum metabolomics analysis reveals changes in signaling lipids in breast cancer patients. Biomed Chromatogr. 2016;30(1):42–47.
   PubMed Web of Science ®Google Scholar
• Lv W, Yang T. Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clin Biochem. 2012;45(1–2):127–133.
   PubMed Web of Science ®Google Scholar
• Mazzone PJ, Wang XF, Beukemann M, et al. Metabolite profiles of the serum of patients with non-small cell carcinoma. J Thorac Oncol. 2016;11(1):72–78.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song L, Liu N, et al. Decreased serum levels of free fatty acids are associated with breast cancer. Clin Chim Acta. 2014;437:31–37.
   PubMed Web of Science ®Google Scholar
• Liu J, Mazzone PJ, Cata JP, et al. Serum free fatty acid biomarkers of lung cancer. Chest. 2014;146(3):670–679.
   PubMed Web of Science ®Google Scholar
• Sylvester KG, Kastenberg ZJ, Moss RL, et al. Acylcarnitine profiles reflect metabolic vulnerability for necrotizing enterocolitis in newborns born premature. J Pediatr. 2017;181:80.e1–85.e1.
   Web of Science ®Google Scholar
• Ryckman KK, Shchelochkov OA, Cook DE, et al. The influence of maternal disease on metabolites measured as part of newborn screening. J Matern Fetal Neonatal Med. 2013;26(14):1380–1383.
   PubMed Web of Science ®Google Scholar
• Kaluarachchi DC, Smith CJ, Klein JM, et al. Polymorphisms in urea cycle enzyme genes are associated with persistent pulmonary hypertension of the newborn. Pediatr Res. 2018;83(1):142–147.
   PubMed Web of Science ®Google Scholar
• Sood MM, Murphy MSQ, Hawken S, et al. Association between newborn metabolic profiles and pediatric kidney disease. Kidney Int Rep. 2018;3(3):691–700.
   PubMed Web of Science ®Google Scholar
• Lin J. Too much short chain fatty acids cause neonatal necrotizing enterocolitis. Med Hypotheses. 2004;62(2):291–293.
   PubMed Web of Science ®Google Scholar
• SEER NCI. Fast Stats; 2018 [cited 2018 Jan 05]. Available from: https://seer.cancer.gov/statfacts/.
   Google Scholar
• Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstetr Gynecol. 2010;116(5):1171–1183.
   PubMed Web of Science ®Google Scholar
• Jakobs BS, Wanders RJ. Fatty acid beta-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propionyl-CoA from peroxisomes to mitochondria. Biochem Biophys Res Commun. 1995;213(3):1035–1041.
   PubMed Web of Science ®Google Scholar
• Peluso G, Nicolai R, Reda E, et al. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Phys. 2000;182(3):339–350.
   PubMed Web of Science ®Google Scholar
• Ramsay RR, Gandour RD, van der Leij FR. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta. 2001;1546(1):21–43.
   PubMedGoogle Scholar
• Rogalidou M, Evangeliou A, Stiakaki E, et al. Serum carnitine levels in childhood leukemia. J Pediatr Hematol Oncol. 2010;32(2):e61–e69.
   PubMed Web of Science ®Google Scholar
• Yaris N, Akyüz C, Coşkun T, et al. Serum carnitine levels of pediatric cancer patients. Pediatr Hematol Oncol. 2002;19(1):1–8.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Zhou B, Su M, et al. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients. IJMS. 2013;14(4):8047–8061.
   Google Scholar
• Ke C, Hou Y, Zhang H, et al. Large-scale profiling of metabolic dysregulation in ovarian cancer. Int J Cancer. 2015;136(3):516–526.
   PubMed Web of Science ®Google Scholar
• Barzał JA, Szczylik C, Rzepecki P, et al. Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage. Acta Biochim Pol. 2014;61(4):615–631.
   PubMed Web of Science ®Google Scholar
• Feun L, You M, Wu CJ, et al. Arginine deprivation as a targeted therapy for cancer. CPD. 2008;14(11):1049–1057.
   Google Scholar
• Kim S-H, Roszik J, Grimm EA, et al. Impact of l-arginine metabolism on immune response and anticancer immunotherapy. Front Oncol. 2018;8:67.
   PubMed Web of Science ®Google Scholar
• Rashkovan M, Ferrando A. Metabolic dependencies and vulnerabilities in leukemia. Genes Dev. 2019;33(21–22):1460–1474.
   PubMed Web of Science ®Google Scholar
• Zou S, Wang X, Liu P, et al. Arginine metabolism and deprivation in cancer therapy. Biomed Pharmacother. 2019;118:109210.
   PubMed Web of Science ®Google Scholar
• Patil MD, Bhaumik J, Babykutty S, et al. Arginine dependence of tumor cells: targeting a chink in cancer's armor. Oncogene. 2016;35(38):4957–4972.
   PubMed Web of Science ®Google Scholar
• Weckman AM, McDonald CR, Baxter JB, et al. Perspective: L-arginine and L-citrulline supplementation in pregnancy: a potential strategy to improve birth outcomes in low-resource settings. Adv Nutr. 2019;10(5):765–777.
   PubMed Web of Science ®Google Scholar
• Rashidi A, Kaiser T, Graiziger C, et al. Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation. Cancer. 2020;126(7):1434–1447.
   PubMed Web of Science ®Google Scholar
• Holm MB, Bastani NE, Holme AM, et al. Uptake and release of amino acids in the fetal-placental unit in human pregnancies. PloS One. 2017;12(10):e0185760.
   PubMed Web of Science ®Google Scholar
• Jansson T. Amino acid transporters in the human placenta. Pediatr Res. 2001;49(2):141–147.
   PubMed Web of Science ®Google Scholar
• Endo F, Matsuura T, Yanagita K, et al. Clinical manifestations of inborn errors of the urea cycle and related metabolic disorders during childhood. J Nutr. 2004;134(6):1605S–1609S.
   PubMed Web of Science ®Google Scholar
• Ware LB, Magarik JA, Wickersham N, et al. Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis. Crit Care. 2013;17(1):R10.
   PubMed Web of Science ®Google Scholar
• Rinaldo P, Cowan TM, Matern D. Acylcarnitine profile analysis. Genet Med. 2008;10(2):151–156.
   PubMed Web of Science ®Google Scholar
• Yoon H-R. Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry. Ann Pediatr Endocrinol Metab. 2015;20(3):119–124.
   PubMedGoogle Scholar